Evidence map›Paper›PMID 42311244›Full record

ArticleFrontiers in oncology2026

Xiaohong Yi, Xianwen Zhang, Lijun Huang, Yuhui Chen, Maochun You, Hongyi Jia, Lefeng Hou, Chao Hu, Kun Huang, Yumei Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaohong Yi *School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine (CDUTCM), Chengdu, China.
Xianwen Zhang *School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine (CDUTCM), Chengdu, China.
Lijun HuangSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine (CDUTCM), Chengdu, China.
Yuhui ChenSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine (CDUTCM), Chengdu, China.
Maochun YouSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine (CDUTCM), Chengdu, China.
Hongyi JiaSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine (CDUTCM), Chengdu, China.
Lefeng HouDepartment of Neurosurgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Medical University, Guangzhou, China.
Chao HuChinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, Chengdu, China.
Kun HuangDepartment of General Surgery, Mianyang Hospital of Traditional Chinese Medicine, Mianyang, Sichuan, China.
Yumei WangSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine (CDUTCM), Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We performed a systematic pan-cancer analysis of Results: Conclusions: Collectively, our findings identify

Indexed as

gliomapan-cancer analysisPI3K-AKT pathwayRNA-seqZNF25

Identifiers

PMID42311244
PMCPMC13268941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.